reference/3785573

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3785573

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	3083
issn	0732-183X 1527-7755
issueIdentifier	18
pageRange	3076-3083
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	3076
bibliographicCitation	Sequist LV, Besse B, Lynch TJ, Miller VA, Wong KK, Gitlitz B, Eaton K, Zacharchuk C, Freyman A, Powell C, Ananthakrishnan R, Quinn S, Soria JC. Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2010 Jun 20;28(18):3076–83. doi: 10.1200/jco.2009.27.9414. PMID: 20479403.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5025-2001 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00359f4dea2659383ce72344ae64ce6d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa95dc87a9fc1b824427414d0d95b9a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16e50495893cadf39e63939d803aeb4f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23d3f7680ffa3195f63071359d059b52 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b4e8edc0bbe2061c64c9b296e23c919 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c81819c8c559f32b7d547278a300a9e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0bc7baa39d258c6be98ddcefbaac846 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75cc22d8dd1ff7e2307bec0027d680f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64846dce006d14608bb49a6576b31c29 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80f463c54fb06c793f08ec1fa0688f0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59d875af7630ce56e5038e4e945ccc69 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91b9565b0489f6168d8a5b71fd4158c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51b8502afe3362df0331dd1d1b3aab30
date	2010-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/20479403 https://doi.org/10.1200/jco.2009.27.9414
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/0732-183X https://portal.issn.org/resource/ISSN/1527-7755
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer
discusses	http://id.nlm.nih.gov/mesh/M0028048 http://id.nlm.nih.gov/mesh/M0495206 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0543872 http://id.nlm.nih.gov/mesh/M0018350 http://id.nlm.nih.gov/mesh/M0500817
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000230Q000188 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D011804Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000230Q000473 http://id.nlm.nih.gov/mesh/D018719Q000037 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D000230Q000378 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008175Q000378 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D002289Q000378 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D007390 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D009154Q000235 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D066246Q000235 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D015996
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9915743 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1956 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245740308

Total number of triples: 75.